A study that evaluated a high dose of vitamin D on the serum biomarkers such as NSE has not been conducted, but in the current study, we evaluated the NSE serum levels in moderated ischemic stroke patients but did not find any significant difference between the two arms of the study regarding this biomarker. The gene discussed is ENO2; the disease is ischemic stroke.